Press Releases | Medtronic

Month Year

Email alerts

Sep 22, 2020

Medtronic Receives FDA "Breakthrough Device Designation" for TYRX Driveline Wrap Device

Medtronic plc (NYSE:MDT), the global leader in medical technology, has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the TYRX™ Absorbable...
Sep 16, 2020

Medtronic TYRX™ Absorbable Antibacterial Envelope Is Cost Effective for Patients at Increased Risk of Infections

Economic Analysis of the WRAP-IT Patient Population in Circulation: Arrhythmia and Electrophysiology

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced new data from the landmark WRAP-IT study, showing the TYRX™ Absorbable Antibacterial Envelope (TYRX Envelope)...
Sep 11, 2020

Medtronic CEO Geoff Martha to Speak at Morgan Stanley Global Healthcare Conference

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September...
Sep 10, 2020

Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly

PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD)

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of primary data from PRODIGY (PRediction of Opioid-induced respiratory Depression In patients...
Sep 9, 2020

Medtronic Receives Breakthrough Device Designation from FDA, Begins Early Feasibility Study for Investigational Intrepid™ Transcatheter Valve System for the Treatment of Tricuspid Valve Regurgitation

Medtronic plc (NYSE:MDT), a global leader in structural heart therapies, today announced U.S. Food and Drug Administration (FDA) approval of an early feasibility study (EFS) of the Intrepid™...
Sep 4, 2020

Medtronic EVP & CFO Karen L. Parkhill To Participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference on Thursday, September 10, 2020.
Sep 1, 2020

Medtronic Announces FDA Approval for Minimed™ 770G Insulin Pump System with Smartphone Connectivity for People with Type 1 Diabetes

New Smartphone Connected Hybrid Closed Loop System Will Be Available to Individuals as Young as 2

DUBLIN – September 1, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its...
Aug 29, 2020

Medtronic Cryoablation Superior to Drug Therapy for Symptomatic Paroxysmal Atrial Fibrillation

ESC Congress: New Research Highlights First-Line Use of Cryoablation as Highly Effective, and with Improved Quality of Life Scores

DUBLIN, Aug. 29, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced clinical trial results demonstrating superiority of the Arctic Front™...
Aug 25, 2020

Medtronic Reports First Quarter Financial Results

Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic

DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2021, which ended July 31, 2020. The company reported...
Aug 24, 2020

Medtronic Board Appoints Kevin Lofton as a New Director

DUBLIN, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that its Board of Directors appointed Kevin Lofton to the Board as an independent director, effective September...

Show per page